Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer (DaeMon)

This study has been completed.
Information provided by (Responsible Party):
Jian Xiao, Sixth Affiliated Hospital, Sun Yat-sen University Identifier:
First received: March 27, 2012
Last updated: November 6, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)